References

Characterize Cancer: Tissue Profiling¹

  • 741 genes for expanded genotyping

  • 47 promoter methylation genes

  • RNA-based fusion detection for a comprehensive view of
    common and rare fusions and splice isoforms

CHARACTERIZE CANCER

Profile tumors to reveal current and emerging cancer biomarkers with our cutting-edge technology.

Characterize Cancer: Liquid Profiling¹

  • 753 genes for expanded genotyping

  • Methylation-based tumor fraction to quantify disease burden